“…Several case reports have also been published (Tables 1D and 2D). 39,41 Essential thrombocythemia: Essential thrombocythemia is a myeloproliferative neoplasm characterized by JAK/STAT pathway activation, leading to elevated platelet levels with an increased risk of thrombosis, including in the SV with consequent SVH. The estimated prevalence of SVT is 4% to 13%.…”